High-intensity focused ultrasound (HIFU) in localized prostate cancer treatment

doi:10.12659/PJR.892341

High-intensity focused ultrasound (HIFU) in localized prostate cancer treatment

Communities & Collections

pcg.skipToMenu

High-intensity focused ultrasound (HIFU) in localized prostate cancer treatment

View Usage Statistics

Bibliographic description

title:	High-intensity focused ultrasound (HIFU) in localized prostate cancer treatment
author:	Alkhorayef Mohammed, Mahmoud Mustafa Z., Alzimami Khalid S., Sulieman Abdelmoneim, Fagiri Maram A.
journal title:	Polish Journal of Radiology
volume:	80
date of publication :	2015
pages:	131-141
ISSN:	1733-134X
eISSN:	1899-0967
DOI:	10.12659/PJR.892341
notes:	Bibliogr. s. 140-141
language:	English
journal language:	English
abstract in English:	Background: High-intensity focused ultrasound (HIFU) applies high-intensity focused ultrasound energy to locally heat and destroy diseased or damaged tissue through ablation. This study intended to review HIFU to explain the fundamentals of HIFU, evaluate the evidence concerning the role of HIFU in the treatment of prostate cancer (PC), review the technologies used to perform HIFU and the published clinical literature regarding the procedure as a primary treatment for PC. Material and Methods: Studies addressing HIFU in localized PC were identified in a search of internet scientific databases. The analysis of outcomes was limited to journal articles written in English and published between 2000 and 2013. Results: HIFU is a non-invasive approach that uses a precisely delivered ultrasound energy to achieve tumor cell necrosis without radiation or surgical excision. In current urological oncology, HIFU is used clinically in the treatment of PC. Clinical research on HIFU therapy for localized PC began in the 1990s, and the majority of PC patients were treated with the Ablatherm device. Conclusions: HIFU treatment for localized PC can be considered as an alternative minimally invasive therapeutic modality for patients who are not candidates for radical prostatectomy. Patients with lower pre-HIFU PSA level and favourable pathologic Gleason score seem to present better oncologic outcomes. Future advances in technology and safety will undoubtedly expand the HIFU role in this indication as more of patient series are published, with a longer follow-up period.
keywords in English:	high-intensity focused ultrasound ablation, magnetic resonance imaging, prostatic neoplasms, interventional
type:	journal article
subtype:	review article

Files in this item

Name: alkhorayef_mahmou ...

Size: 266.1Kb

Format: PDF

View/Open

This item appears in the following Collection(s)

Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 3.0 Polska

Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 3.0 Polska